Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_assertion type Assertion NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_head.
- NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_assertion description "[The GSTM1 null genotype, however, was significantly overrepresented among larger (T3 and T4) primary tumors (OR 7.61, 0.95 CI 1.05-333) and with the occurrence of axillary lymph node metastases (OR 1.62, 0.95 CI 0.98-2.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_provenance.
- NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_assertion evidence source_evidence_literature NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_provenance.
- NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_assertion SIO_000772 11810042 NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_provenance.
- NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_assertion wasDerivedFrom befree-20140225 NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_provenance.
- NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_assertion wasGeneratedBy ECO_0000203 NP484794.RAAELW3d-xFYH3tlN1LzvU3e0mRGtTmiK_2hEbG8VdqJY130_provenance.